2021 ICD-10-CM Code C50.12

Malignant neoplasm of central portion of breast, male

Version 2021

Not Valid for Submission

C50.12 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of malignant neoplasm of central portion of breast, male. The code is not specific and is NOT valid for the year 2021 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

ICD-10:C50.12
Short Description:Malignant neoplasm of central portion of breast, male
Long Description:Malignant neoplasm of central portion of breast, male

Code Classification

Specific Coding for Malignant neoplasm of central portion of breast, male

Non-specific codes like C50.12 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for malignant neoplasm of central portion of breast, male:

  • BILLABLE CODE - Use C50.121 for Malignant neoplasm of central portion of right male breast
  • BILLABLE CODE - Use C50.122 for Malignant neoplasm of central portion of left male breast
  • BILLABLE CODE - Use C50.129 for Malignant neoplasm of central portion of unspecified male breast

Information for Patients


Male Breast Cancer

Although breast cancer is much more common in women, men can get it too. It happens most often to men between the ages of 60 and 70.

Breast lumps usually aren't cancer. However, most men with breast cancer have lumps. Other breast symptoms can include

Risk factors for male breast cancer include exposure to radiation, a family history of breast cancer, and having high estrogen levels, which can happen with diseases like cirrhosis or Klinefelter's syndrome.

Treatment for male breast cancer is usually a mastectomy, which is surgery to remove the breast. Other treatments include radiation, chemotherapy and/or hormone therapy.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)